Bio-Rad Laboratories Total Assets 2010-2024 | BIO

Bio-Rad Laboratories total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Bio-Rad Laboratories total assets for the quarter ending September 30, 2024 were $10.603B, a 10.86% decline year-over-year.
  • Bio-Rad Laboratories total assets for 2023 were $12.299B, a 8.91% decline from 2022.
  • Bio-Rad Laboratories total assets for 2022 were $13.502B, a 24.15% decline from 2021.
  • Bio-Rad Laboratories total assets for 2021 were $17.799B, a 37.21% increase from 2020.
Bio-Rad Laboratories Annual Total Assets
(Millions of US $)
2023 $12,299
2022 $13,502
2021 $17,799
2020 $12,973
2019 $8,009
2018 $5,611
2017 $4,273
2016 $3,851
2015 $3,710
2014 $3,341
2013 $3,389
2012 $3,444
2011 $3,097
2010 $3,063
2009 $2,536
Bio-Rad Laboratories Quarterly Total Assets
(Millions of US $)
2024-09-30 $10,603
2024-06-30 $9,688
2024-03-31 $12,610
2023-12-31 $12,299
2023-09-30 $11,896
2023-06-30 $11,978
2023-03-31 $13,667
2022-12-31 $13,502
2022-09-30 $12,058
2022-06-30 $12,682
2022-03-31 $14,374
2021-12-31 $17,799
2021-09-30 $19,953
2021-06-30 $15,118
2021-03-31 $13,933
2020-12-31 $12,973
2020-09-30 $12,021
2020-06-30 $10,097
2020-03-31 $8,684
2019-12-31 $8,009
2019-09-30 $7,177
2019-06-30 $7,647
2019-03-31 $6,863
2018-12-31 $5,611
2018-09-30 $6,719
2018-06-30 $6,386
2018-03-31 $6,215
2017-12-31 $4,273
2017-09-30 $4,186
2017-06-30 $4,143
2017-03-31 $3,953
2016-12-31 $3,851
2016-09-30 $4,020
2016-06-30 $3,875
2016-03-31 $3,753
2015-12-31 $3,710
2015-09-30 $3,666
2015-06-30 $3,525
2015-03-31 $3,326
2014-12-31 $3,341
2014-09-30 $3,386
2014-06-30 $3,468
2014-03-31 $3,441
2013-12-31 $3,389
2013-09-30 $3,280
2013-06-30 $3,483
2013-03-31 $3,457
2012-12-31 $3,444
2012-09-30 $3,303
2012-06-30 $3,169
2012-03-31 $3,188
2011-12-31 $3,097
2011-09-30 $2,970
2011-06-30 $3,044
2011-03-31 $2,909
2010-12-31 $3,063
2010-09-30 $2,682
2010-06-30 $2,527
2010-03-31 $2,547
2009-12-31 $2,536
2009-09-30 $2,478
2009-06-30 $2,344
2009-03-31 $1,955
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.670B $2.671B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $222.392B 27.46
Boston Scientific (BSX) United States $154.781B 41.84
Stryker (SYK) United States $150.988B 32.49
EssilorLuxottica (ESLOY) France $128.761B 0.00
Medtronic (MDT) Ireland $116.457B 17.30
Lonza Group Ag (LZAGY) Switzerland $48.724B 0.00
Haleon (HLN) United Kingdom $43.049B 27.97
Agilent Technologies (A) United States $42.120B 27.91
GE HealthCare Technologies (GEHC) United States $40.456B 20.98
ResMed (RMD) United States $34.834B 26.83
Terumo (TRUMY) Japan $27.701B 39.39
Koninklijke Philips (PHG) Netherlands $25.801B 19.75
Zimmer Biomet Holdings (ZBH) United States $20.443B 12.84
Insulet (PODD) United States $20.179B 80.36
Baxter (BAX) United States $15.731B 10.24
Smith & Nephew SNATS (SNN) United Kingdom $11.039B 0.00
Sunny Optical Technology (SNPTF) China $9.976B 0.00
BellRing Brands (BRBR) United States $9.951B 37.15
Demant (WILYY) Denmark $7.946B 0.00
Lantheus Holdings (LNTH) United States $6.320B 14.69
Prestige Consumer Healthcare (PBH) United States $4.316B 20.65
ICU Medical (ICUI) United States $3.878B 36.92
Envista Holdings (NVST) United States $3.750B 29.85
Perrigo (PRGO) Ireland $3.407B 10.03
Haemonetics (HAE) United States $3.164B 14.89
GN Store Nord (GNNDY) Denmark $3.123B 21.05
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.832B 18.23
Neogen (NEOG) United States $2.315B 26.67
LeMaitre Vascular (LMAT) United States $2.245B 54.55
AtriCure (ATRC) United States $1.997B 0.00
Green Thumb Industries (GTBIF) United States $1.513B 26.48
AdaptHealth (AHCO) United States $1.300B 9.29
InMode (INMD) Israel $1.269B 10.61
Maravai LifeSciences Holdings (MRVI) United States $1.250B 0.00
BioLife Solutions (BLFS) United States $1.215B 0.00
Curaleaf Holdings (CURLF) Canada $1.069B 0.00
Phibro Animal Health (PAHC) United States $0.996B 15.27
Evolus (EOLS) United States $0.849B 0.00
CeriBell (CBLL) United States $0.810B 0.00
Owens & Minor (OMI) United States $0.667B 5.21
Capricor Therapeutics (CAPR) United States $0.652B 0.00
VAREX IMAGING (VREX) United States $0.627B 27.14
Valneva SE (VALN) France $0.563B 0.00
Omeros (OMER) United States $0.526B 0.00
SNDL (SNDL) Canada $0.507B 0.00
Surmodics (SRDX) United States $0.487B 0.00
Cresco Labs (CRLBF) United States $0.474B 0.00
Verano Holdings (VRNOF) United States $0.424B 0.00
ZimVie (ZIMV) United States $0.383B 32.26
Canopy Growth (CGC) Canada $0.363B 0.00
Aurora Cannabis (ACB) Canada $0.343B 62.50
Cerus (CERS) United States $0.323B 0.00
Quanterix (QTRX) United States $0.320B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.11
Sanara MedTech (SMTI) United States $0.309B 0.00
OraSure Technologies (OSUR) United States $0.292B 19.55
Biote (BTMD) United States $0.261B 5.73
Zynex (ZYXI) United States $0.252B 52.80
High Tide (HITI) Canada $0.238B 0.00
Sanuwave Health (SNWV) United States $0.232B 3.26
SEMPERIT AG HLD (SEIGY) Austria $0.226B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
TerrAscend (TSNDF) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.203B 15.16
Brainsway (BWAY) Israel $0.200B 106.40
MacroGenics (MGNX) United States $0.174B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
FitLife Brands (FTLF) United States $0.142B 17.83
Jin Medical (ZJYL) China $0.130B 0.00
Quipt Home Medical (QIPT) United States $0.127B 0.00
Fonar (FONR) United States $0.101B 11.44
Exagen (XGN) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Veru (VERU) United States $0.085B 0.00
InterCure (INCR) Israel $0.080B 0.00
Jushi Holdings (JUSHF) United States $0.073B 0.00
INLIF (INLF) $0.067B 0.00
Rockwell Medical (RMTI) United States $0.064B 33.00
Cytosorbents (CTSO) United States $0.057B 0.00
Ayr Wellness (AYRWF) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
MariMed (MRMD) United States $0.051B 0.00
United-Guardian (UG) United States $0.051B 14.60
Modular Medical (MODD) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00